Document is current
Any future updates will be listed below
-
Authors
De Bacco, Francesca
D'Ambrosio, Antonio
Casanova, Elena
Orzan, Francesca
Neggia, Roberta
Albano, Raffaella
Verginelli, Federica
Cominelli, Manuela
Poliani, Pietro L
Luraghi, Paolo
Reato, Gigliola
Pellegatta, Serena
Finocchiaro, Gaetano
Perera, Timothy
Garibaldi, Elisabetta
Gabriele, Pietro
Comoglio, Paolo M
Boccaccio, Carla https://orcid.org/0000-0003-2620-9083
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (9970)
Associazione Italiana per la Ricerca sul Cancro (IG 10446)
Associazione Italiana per la Ricerca sul Cancro (15709)
Associazione Italiana per la Ricerca sul Cancro (11852)
Ministero della Salute
Comitato per Albi98
- License Information
-
More Information
Article History
Received: 16 October 2015
Revised: 26 February 2016
Accepted: 2 March 2016
First Online: 4 April 2016
Conflict of interest
: TP was a former employee of Ortho Biotech Oncology Discovery Research, Janssen Pharmaceutica, that provided the MET inhibitor JNJ38877605, but he was not involved in collection, analysis, and interpretation of results concerning the inhibitor. He is founder of Octimet Oncology Ltd and member of the scientific advisory board. The other authors declare that they have no conflict of interest.
